BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33893149)

  • 21. Identification of Sp1-elements in the promoter region of human homeobox gene NKX3.1.
    Yu CX; Jin T; Chen WW; Zhang PJ; Liu WW; Guan HY; Zhang J; Liu QW; Jiang AL
    Mol Biol Rep; 2009 Nov; 36(8):2353-60. PubMed ID: 19263243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antioxidant treatment promotes prostate epithelial proliferation in Nkx3.1 mutant mice.
    Martinez EE; Anderson PD; Logan M; Abdulkadir SA
    PLoS One; 2012; 7(10):e46792. PubMed ID: 23077524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
    Martinez EE; Darke AK; Tangen CM; Goodman PJ; Fowke JH; Klein EA; Abdulkadir SA
    Cancer Prev Res (Phila); 2014 Sep; 7(9):950-7. PubMed ID: 24894197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Nkx3.1 enhances 17beta-estradiol anti-tumor action in PC3 human prostate cancer cells.
    Wang P; Liu B; Luo JD; Zhang ZG; Ma Q; Chen ZD
    Asian J Androl; 2007 May; 9(3):353-60. PubMed ID: 17486276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
    Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
    Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nkx3.1 functions as para-transcription factor to regulate gene expression and cell proliferation in non-cell autonomous manner.
    Zhou J; Qin L; Tien JC; Gao L; Chen X; Wang F; Hsieh JT; Xu J
    J Biol Chem; 2012 May; 287(21):17248-17256. PubMed ID: 22465996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional analysis of NKX3.1 in LNCaP prostate cancer cells by RNA interference.
    Possner M; Heuser M; Kaulfuss S; Scharf JG; Schulz W; Hermann-Ringert R; Thelen P
    Int J Oncol; 2008 Apr; 32(4):877-84. PubMed ID: 18360715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NKX3.1 activates cellular response to DNA damage.
    Bowen C; Gelmann EP
    Cancer Res; 2010 Apr; 70(8):3089-97. PubMed ID: 20395202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.
    Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z
    Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of NKX3.1 and C-MYC expression in canine prostatic cancer.
    Fonseca-Alves CE; Kobayashi PE; Laufer-Amorim R
    Res Vet Sci; 2018 Jun; 118():365-370. PubMed ID: 29665565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and androgen regulation of the human homeobox cDNA, NKX3.1.
    Prescott JL; Blok L; Tindall DJ
    Prostate; 1998 Apr; 35(1):71-80. PubMed ID: 9537602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ETS1 regulates NKX3.1 5' promoter activity and expression in prostate cancer cells.
    Preece DM; Harvey JM; Bentel JM; Thomas MA
    Prostate; 2011 Mar; 71(4):403-14. PubMed ID: 20842667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NKX3.1 haploinsufficiency is prognostic for prostate cancer relapse following surgery or image-guided radiotherapy.
    Locke JA; Zafarana G; Ishkanian AS; Milosevic M; Thoms J; Have CL; Malloff CA; Lam WL; Squire JA; Pintilie M; Sykes J; Ramnarine VR; Meng A; Ahmed O; Jurisica I; van der Kwast T; Bristow RG
    Clin Cancer Res; 2012 Jan; 18(1):308-16. PubMed ID: 22048240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
    Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
    Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
    Thomas MA; Preece DM; Bentel JM
    Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line.
    Jiang A; Yu C; Zhang P; Chen W; Liu W; Hu X; Zhang J
    Exp Mol Med; 2006 Dec; 38(6):625-33. PubMed ID: 17202838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NKX3.1 contributes to S phase entry and regulates DNA damage response (DDR) in prostate cancer cell lines.
    Erbaykent-Tepedelen B; Ozmen B; Varisli L; Gonen-Korkmaz C; Debelec-Butuner B; Muhammed Syed H; Yilmazer-Cakmak O; Korkmaz KS
    Biochem Biophys Res Commun; 2011 Oct; 414(1):123-8. PubMed ID: 21945437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis.
    Anderson PD; McKissic SA; Logan M; Roh M; Franco OE; Wang J; Doubinskaia I; van der Meer R; Hayward SW; Eischen CM; Eltoum IE; Abdulkadir SA
    J Clin Invest; 2012 May; 122(5):1907-19. PubMed ID: 22484818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of an inhibitory cis-element in the promoter region of human homeobox gene NKX3.1.
    Anli J; Pengju Z; Xiaoyan H; Wenwei C; Zhifang L; Feng K; Huiqing Y; Jianye Z
    Prostate; 2006 Sep; 66(12):1339-46. PubMed ID: 16845664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Full-length cDNA sequence and genomic organization of human NKX3A - alternative forms and regulation by both androgens and estrogens.
    Korkmaz KS; Korkmaz CG; Ragnhildstveit E; Kizildag S; Pretlow TG; Saatcioglu F
    Gene; 2000 Dec; 260(1-2):25-36. PubMed ID: 11137288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.